IR Releases

IR-Releases

We will keep you informed. Here you will find our (ad-hoc-) releases for investors.

2023

Alexander Müller leaves apoBank Board of Directors for a new job

12.01.2023

* IR Release is only available in German.

More

2022

apobank adopts Agenda 2025

12.12.2022

* IR Release is only available in German.

More

Holger Wessling leaves apoBank Board of Directors for a new job

15.11.2022

* IR Release is only available in German.

More

Eckhard Lüdering leaves apoBank Board of Directors

30.09.2022

* IR Release is only available in German.

More

Board member Jenny Friese leaves apoBank

13.09.2022

* IR Release is only available in German.

More

apobank appoints two new board members

08.09.2022

* IR Release is only available in German.

More

apoBank reports slightly higher operating result

30.08.2022 - Deutsche Apotheker- und Ärztebank (apoBank) generated a net profit after tax of €32.8 million (30 June 2021: €37.0 million) in the first half of 2022.

More

Annual General Meeting 2022

29.04.2022

* IR Release is only available in German.
 
More

apoBank reports satisfactory 2021 business performance

07.04.2022 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2021 with a stable net profit of €65.4 million, compared to €65.3 million in 2020.

More

Matthias Schellenberg becomes new CEO of apoBank

21.01.2022 - At its meeting on January 21, the Supervisory Board of Deutsche Apotheker- und Ärztebank (apoBank) appointed Matthias Schellenberg (57) as the new CEO.

More

* IR Release is only available in German.

2021

Changes in the management board

10.12.2021 - Ulrich Sommer (59), Chairman of the Management Board is leaving apoBank on December 10th.

More

* IR Release is only available in German.

apoBank posts stable operating income

31.08.2021 - Deutsche Apotheker- und Ärztebank (apoBank) completed the first six months of 2021 with a net profit of €37.0 million (30 June 2020: €32.7 million).

More

Changes in the management board and Annual General Meeting 2021

30.04.2021

* IR Release is only available in German.

More

apoBank reports satisfactory 2020 business performance

15.04.2021 - Deutsche Apotheker- und Ärztebank (apoBank) closed financial 2020 with a stable net profit of €65.3 million compared to €64.1 million in 2019.

More

New board member starts at apobank

04.01.2021 - Jenny Friese has been head of the major customers and markets department since January 1st 2021.

More

* IR Release is only available in German.

2020

New appointments to the sales departments

02.10.2020 - Supervisory board of Deutsche Apotheker- und Ärztebank (apoBank) has newly appointed the board of directors "Private Customers" and "Large Customers and Markets". The press release is only available in German. You find it here.
 

apoBank reports satisfactory interim result

27.08.2020 - Deutsche Apotheker- und Ärztebank (apoBank) completed the first six month of 2020 with a stable net profit of €32.7 million (30 June 2019: €31.9 million).

More

Annual General Meeting: apoBank members receive a 2 percent dividend

06.05.2020 - The Annual General Meeting took place on Wednesday 6 May 2020. The acompanying press release is available in German only. You will find it here.

apoBank: Respectable result in an environment that remains challenging

01.04.2020 - In fiscal 2019, Deutsche Apotheker- und Ärztebank (apoBank) achieved a stable net profit after tax of €64.1 million (2018: €62.9 million).

More

2019

apoBank continues to expand its customer business

29.08.2019 - Deutsche Apotheker- und Ärztebank (apoBank) generated a stable net profit of €31.9 million (30 June 2018: €31.4 million) in the first six months of 2019.

More

apoBank: Strong base on which to expand business model

08.04.2019 - Deutsche Apotheker- und Ärztebank (apoBank) achieved a stable net profit after tax of €62.9 million (2017: €61.9 million) in fiscal 2018.

More

2018

apoBank expands operating income in the first six months of 2018

30.08.2018 - Deutsche Apotheker- und Ärztebank (apoBank) completed the first six months of 2018 with a stable net profit of €31.4 million in a challenging environment.

More
 

apoBank: Leading market position strengthened

18.04.2018 - Deutsche Apotheker- und Ärztebank (apoBank) achieved a stable net profit after tax of €61.9 million (2016: €61.0 million) in the 2017 financial year.

More

2017

apoBank posts pleasing result in the first half of 2017

30.08.2017 - After making allocations to reserves once again, Deutsche Apotheker- und Ärztebank (apoBank) completed the first six months of 2017 with a stable net profit of €30.9 million.

More

apoBank: Leading market position strengthened

04.04.2017 - Deutsche Apotheker- und Ärztebank (apoBank) completed financial 2016 with an operating result of €159.6 million, an increase of 4.0% on the previous year’s figure.

More

2016

apoBank does well in spite of difficult environment

25.08.2016 - apoBank completed the first six months of 2016 with a net profit of €30.4 million, thus exceeding the level of the previous year’s period.

More

apoBank reorganises its rating structure

03.05.2016 - apoBank has reviewed its rating relationships with the rating agencies Moody's Investors Service and Standard and Poor's.

More

apoBank increases operating result

19.04.2016 - Deutsche Apotheker- und Ärztebank (apoBank) completed the 2015 financial year with an operating result of €153.4 million, considerably exceeding the previous year’s figure.

More

2015

apoBank successfully placed Benchmark-Hypothekenpfandbrief

apoBank continues on growth path

26.08.2015 - In the first six months of 2015, after further allocations to reserves, apoBank achieved a net profit after tax of €27.4 million, an increase on the previous year’s figure.

More

Moody's upgrades apoBank

apoBank: Annual General Meeting 2015

apoBank continues on growth path in 2014

21.04.2015 - apoBank's net profit after tax rose significantly to €54.5 million (2013: €47.4 million).

More

2014

apoBank terminates Silent Participation

apoBank achieves very good result in ECB Stress Test

apoBank on growth path with good interim result

27.08.2014 - apoBank completed the first six months of 2014 with a net profit of €24.9 million, thus exceeding the level of the same period in the previous year.

More

Moody's raises apoBank’s rating by one notch to "A1"

07.05.2014 - Moody's has upgraded the rating for apoBank. The long-term debt and deposit ratings were raised by one notch from "A2" to "A1".

More

apoBank 2013: Good performance in challenging environment

08.04.2014 - Deutsche Apotheker- und Ärztebank (apoBank) completed financial 2013 with a net profit of €47.4 million (2012: €45.4 million).

More

2013

Moody’s raises outlook for apoBank to "stable"

03.12.2013 - Due to the positive business performance of apoBank, the rating agency Moody’s today raised apoBank’s outlook from negative to stable. Its long-term A2 rating was confirmed.

More

apoBank terminates Silent Participation (only available in German)

apoBank: Number of members and customer base expanded in first six months

29.08.2013 - Net profit of €24.1 million slightly above previous year’s level - Administrative expenses benefit from optimised cost structure - Implementation of customer support concept running according to plan - Outlook for 2013 confirmed: stable net profit and continuous dividend distribution planned.

More

 

apoBank: Foundation for future growth laid in 2012

16.04.2013 - Deutsche Apotheker- und Ärztebank (apoBank) closed 2012 with a net profit of €45.4 million, thus exceeding the result of the previous year (2011: €43.1 million).

More